Carbone DP - Search Results

1

Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung Cancer.

Shukuya T, Carbone DP. Shukuya T, et al. Among authors: carbone dp. J Thorac Oncol. 2016 Jul;11(7):976-88. doi: 10.1016/j.jtho.2016.02.015. Epub 2016 Mar 2. J Thorac Oncol. 2016. PMID: 26944305 Free PMC article. Review.

2

Phase I study of Paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer.

Rosenthal DI, Fuller CD, Machtay M, Algazy KM, Meyer DM, Kaiser LR, Yardley DA, Loiacano ME, Carbone DP. Rosenthal DI, et al. Among authors: carbone dp. J Thorac Oncol. 2006 Jan;1(1):38-45. J Thorac Oncol. 2006. PMID: 17409825 Free article. Clinical Trial.

3

Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.

Salmon S, Chen H, Chen S, Herbst R, Tsao A, Tran H, Sandler A, Billheimer D, Shyr Y, Lee JW, Massion P, Brahmer J, Schiller J, Carbone D, Dang TP. Salmon S, et al. J Thorac Oncol. 2009 Jun;4(6):689-96. doi: 10.1097/JTO.0b013e3181a526b3. J Thorac Oncol. 2009. PMID: 19404214 Free PMC article. Clinical Trial.

4

Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models.

Sun Y, Moretti L, Giacalone NJ, Schleicher S, Speirs CK, Carbone DP, Lu B. Sun Y, et al. Among authors: carbone dp. J Thorac Oncol. 2011 Apr;6(4):699-706. doi: 10.1097/JTO.0b013e31820d9d11. J Thorac Oncol. 2011. PMID: 21325979 Free PMC article.

5

Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms.

Carbone DP, Felip E. Carbone DP, et al. Clin Lung Cancer. 2011 Sep;12(5):261-71. doi: 10.1016/j.cllc.2011.06.002. Epub 2011 Aug 10. Clin Lung Cancer. 2011. PMID: 21831720 Review.

6

A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501.

Wakelee HA, Lee JW, Hanna NH, Traynor AM, Carbone DP, Schiller JH. Wakelee HA, et al. Among authors: carbone dp. J Thorac Oncol. 2012 Oct;7(10):1574-82. doi: 10.1097/JTO.0b013e31826149ba. J Thorac Oncol. 2012. PMID: 22982658 Free PMC article. Clinical Trial.

7

Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trial.

Carbone DP, Ding K, Roder H, Grigorieva J, Roder J, Tsao MS, Seymour L, Shepherd FA. Carbone DP, et al. J Thorac Oncol. 2012 Nov;7(11):1653-60. doi: 10.1097/JTO.0b013e31826c1155. J Thorac Oncol. 2012. PMID: 23059783 Free PMC article. Clinical Trial.

8

An era of lung cancer iconoclasts.

Carbone DP. Carbone DP. J Thorac Oncol. 2014 Apr;9(4):436-7. doi: 10.1097/JTO.0000000000000121. J Thorac Oncol. 2014. PMID: 24736062 Free article. No abstract available.

9

Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer.

Lammers PE, Shyr Y, Li CI, Hutchison AS, Sandler A, Carbone DP, Johnson DH, Keedy VL, Horn L. Lammers PE, et al. Among authors: carbone dp. J Thorac Oncol. 2014 Apr;9(4):559-62. doi: 10.1097/JTO.0000000000000079. J Thorac Oncol. 2014. PMID: 24736081 Free PMC article. Clinical Trial.

10

LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT.

Kaufman JM, Amann JM, Park K, Arasada RR, Li H, Shyr Y, Carbone DP. Kaufman JM, et al. Among authors: carbone dp. J Thorac Oncol. 2014 Jun;9(6):794-804. doi: 10.1097/JTO.0000000000000173. J Thorac Oncol. 2014. PMID: 24828662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page